ClinicalTrials.gg
CompletedNCT07482098Updated Oct 15, 2026

Gastric Ultrasound After Clear Fluid Intake in Diabetic and Non-Diabetic Pregnant Women

An interventional study of Oral water intake in Pregnancy and Gestational Diabetes Mellitus (GDM), sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Dec 2025, registered Mar 2026).
Updated Oct 7, 2026Now CompletedEnrollment updated+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
95
Allocation
Non-randomized
Ages
18 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Diabetes, Gestational with a site in Turkey — 9 open to participants now, 12 under way, none of them phase 3. Diabetes, Gestational · Turkey.

Enrollment
11th of 28
95 · median 85
Started
2025
with 6 others
No phase
28 of 52
5 open now
Registered
47th of 52
by date
Lead sponsor
3 of 52
Ankara City Hospital Bilkent

Among the 52 studies in Diabetes, Gestational with a site in Turkey, this one is the 11th largest by enrollment of the 28 interventional ones that give a count, is one of 7 that started in 2025, is one of 28 with no phase, and was the 47th registered.

Diabetes, Gestational

878 studies on the registry are indexed under Diabetes, Gestational; 196 are open to participants now.

Browse Diabetes, Gestational studies →

Open to participants now

9 of the 52 studies in Diabetes, Gestational with a site in Turkey are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 132 Diabetes, Gestational studies recruiting now, 60 (45%) set no upper age limit and 70 (53%) stop at 75 or younger; 12 take children under 18; 60 take healthy volunteers.

This study: 18 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Diabetes, Gestational with a site in Turkey, or all of them as a file.
02

Study summary

Pulmonary aspiration of gastric contents during anesthesia is a serious perioperative complication associated with significant morbidity and mortality. Pregnant women are at increased risk of aspiration because of physiological changes such as delayed gastric emptying and increased intra-abdominal pressure. In addition, gestational diabetes mellitus (GDM) may affect gastric motility and gastric emptying.

Current fasting guidelines allow the intake of clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in pregnant women with GDM remains unclear.

This prospective interventional study compares gastric volume measured by gastric ultrasonography in term pregnant women with and without gestational diabetes mellitus (GDM) undergoing elective cesarean delivery. Participants receive 200 mL of oral water after baseline gastric ultrasonography. Gastric ultrasonography is performed before water intake (T1), immediately after completion of water intake (T2), and two hours after water intake immediately before anesthesia (T3) to evaluate gastric volume and gastric content.

The study aims to improve the assessment of gastric volume and perioperative fasting in pregnant women, particularly those with gestational diabetes mellitus.

Read the detailed description

Pulmonary aspiration of gastric contents is one of the most feared complications of obstetric anesthesia and may lead to significant morbidity and mortality. Pregnancy is associated with physiological changes including increased intra-abdominal pressure, gastroesophageal reflux, and alterations in gastric emptying, which may increase perioperative aspiration risk. Gestational diabetes mellitus (GDM) may further affect gastric motility and gastric emptying.

Preoperative fasting guidelines from major anesthesia societies allow the intake of clear fluids up to two hours before anesthesia. However, the effect of preoperative oral clear fluid intake on gastric volume in pregnant women with gestational diabetes mellitus remains unclear.

This single-center prospective interventional study evaluates term pregnant women scheduled for elective cesarean delivery. Participants are included in two groups according to the presence or absence of gestational diabetes mellitus. The GDM group includes women with gestational diabetes mellitus managed with diet or insulin during pregnancy, while the control group includes pregnant women without GDM.

After standard preoperative fasting, baseline gastric ultrasonography is performed immediately before oral fluid intake (T1). Participants then consume 200 mL of room-temperature drinking water orally. Gastric ultrasonography is repeated immediately after completion of water intake (T2) and two hours after water intake, immediately before anesthesia (T3).

Gastric ultrasonography is performed in the semi-recumbent and right lateral decubitus positions. The gastric antrum is identified using anatomical landmarks including the left lobe of the liver, pancreas, aorta, and inferior vena cava. The gastric antral cross-sectional area is calculated using the formula CSA = (D1 × D2 × π) / 4.

Gastric volume is estimated using the Roukhomovsky equation. Gastric contents are also qualitatively assessed using the three-grade Perlas grading system (Grade 0, 1, or 2).

Gastric volume is standardized to body weight in mL/kg. A standardized gastric volume greater than 1.5 mL/kg is classified as exceeding the high gastric volume threshold. This threshold is used as an ultrasonographic indicator of high gastric volume rather than as a direct threshold for pulmonary aspiration.

The primary objective is to compare the pattern of gastric volume change across the three predefined time points between pregnant women with GDM and those without GDM. Secondary assessments include qualitative evaluation of gastric contents using the Perlas grading system and the proportion of participants exceeding the high gastric volume threshold.

03

Conditions studied

  • Pregnancy
  • Gestational Diabetes Mellitus (GDM)

Browse trials for

Keywords

  • Gastric Ultrasound
  • Cesarean Delivery
  • Preoperative Fasting
  • Gastric Volume
  • Pregnant Women
  • high gastric volume
  • Gestational Diabetes Mellitus
04

Who can participate

The criteria were revised on the registry on Oct 7, 2026. See what changed

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women aged 18-40 years
  • Scheduled for elective cesarean delivery
  • II or III
  • Patients who provide written
  • Singleton pregnancy
  • No to regional anesthesia
  • Compliance with standard preoperative fasting requirements

Exclusion criteria

Exclusion Criteria:

  • Active labor
  • Refusal to participate in the study
  • to regional anesthesia
  • Previously diagnosed diabetic gastroparesis
  • Pregestational diabetes mellitus (type 1 or type 2)
  • History of upper gastrointestinal disease or gastroesophageal reflux disease
  • History of esophageal, gastric, or upper abdominal surgery
  • Anatomical abnormalities of the upper gastrointestinal tract
  • IV or higher
  • Inability to adequately visualize the gastric antrum by ultrasonography
  • Pre-existing neurological disease
  • Infection at the spinal puncture site
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
95 participants (actual)

Study arms

  • Experimental
    Gestational Diabetes Mellitus (GDM) Group

    Term pregnant women with gestational diabetes mellitus managed with diet or insulin during pregnancy. Participants receive 200 mL of oral water after baseline gastric ultrasonography and undergo gastric ultrasonography at three predefined time points: before water intake (T1), immediately after water intake (T2), and 2 hours after water intake (T3).

    Other: Oral water intake

  • Experimental
    Control Group

    Term pregnant women without gestational diabetes mellitus. Participants receive 200 mL of oral water after baseline gastric ultrasonography and undergo gastric ultrasonography at three predefined time points: before water intake (T1), immediately after water intake (T2), and 2 hours after water intake (T3).

    Other: Oral water intake

Interventions

  • OtherOral water intake

    Participants consume 200 mL of room-temperature drinking water orally immediately after the baseline gastric ultrasonography assessment (T1). Gastric ultrasonography is then repeated immediately after completion of water intake (T2) and 2 hours after water intake (T3).

06

What researchers measure

Primary outcomes

  1. Gastric Volume Across Three Time Points

    Gastric volume (mL) will be calculated from gastric antral cross-sectional area measurements obtained by ultrasonography using the Roukhomovsky equation. Gastric volume will be assessed at three predefined time points in women with gestational diabetes mellitus and women without gestational diabetes mellitus. The primary outcome is the difference in the pattern of gastric volume change over time between the two groups.

    Time frame: T1: after standard preoperative fasting, immediately before intake of 200 mL water; T2: immediately after completion of 200 mL water intake; T3: 2 hours after water intake, immediately before anesthesia.

Secondary outcomes

  1. Qualitative Assessment of Gastric Contents Using the Perlas Grading System

    Gastric contents will be qualitatively assessed using the three-grade Perlas grading system (Grade 0, 1, or 2) based on ultrasonographic examination in the semi-recumbent and right lateral decubitus positions. The distribution of Perlas grades will be compared between groups and across the three measurement time points.

    Time frame: T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.

  2. Proportion of Participants Exceeding the High Gastric Volume Threshold (>1.5 mL/kg)

    Gastric volume will be standardized to body weight (mL/kg). A standardized gastric volume \>1.5 mL/kg will be classified as exceeding the high gastric volume threshold. This threshold is used as an ultrasonographic classification of high-volume gastric contents and is not considered a direct threshold for pulmonary aspiration. The proportion of participants exceeding this threshold will be compared between groups and across time points.

    Time frame: T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.

07

Study locations

1 site
  • Ankara Bilkent City Hospital
    Ankara, Ankara 06800, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Jul 2026, 7 months.

Of 306 non-industry interventional studies with no phase under Diabetes, Gestational, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 48. This study's 7 months is below that.

Counting every sponsor, half of 309 studies reached it within 28 months; a quarter within 13 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2026
First posted
Mar 19, 2026
StartActual
Dec 1, 2025
Primary completionActual
Jul 29, 2026
CompletionActual
Jul 29, 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 7, 2026
Enrollment
80 (estimated)→95 (actual)
Oct 7, 2026
Eligibility
2 inclusion criteria edited, 2 added; 1 exclusion criterion edited, 8 added, 3 removed
What changed in the criteria
Inclusion criteria
  • EditedScheduled for elective cesarean section under spinal anesthesiadelivery
  • EditedASA physical status II or III
  • AddedNo contraindication to regional anesthesia
  • AddedCompliance with standard preoperative fasting requirements
Exclusion criteria
  • AddedActive labor
  • EditedContraindication to spinalregional anesthesia
  • RemovedKnown allergy to study medications
  • RemovedMultiple pregnancy
  • RemovedSevere systemic disease (ASA III or higher)
  • AddedPreviously diagnosed diabetic gastroparesis
  • AddedPregestational diabetes mellitus (type 1 or type 2)
  • AddedHistory of upper gastrointestinal disease or gastroesophageal reflux disease
  • AddedHistory of esophageal, gastric, or upper abdominal surgery
  • AddedAnatomical abnormalities of the upper gastrointestinal tract
  • AddedASA physical status IV or higher
  • AddedInability to adequately visualize the gastric antrum by ultrasonography
Oct 7, 2026
Interventions
Arms added: Gestational Diabetes Mellitus (GDM) Group·Control Group; arms removed: Diabetic Pregnant Women·Non-Diabetic Pregnant Women
Oct 7, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Gastric Volume Measured by UltrasonographyNow Gastric Volume Across Three Time PointsTime frame: Before oral clear fluid intake and two hours after fluid intake before anesthesia → T1: after standard preoperative fasting, immediately before intake of 200 mL water; T2: immediately after completion of 200 mL water intake; T3: 2 hours after water intake, immediately before anesthesia.
Oct 7, 2026
Secondary outcomes
2 edited
What changed in the outcomes
  • EditedQualitative Assessment of Gastric Contents Using the Perlas Grading SystemTime frame: Before oral clear fluid intake and two hours after fluid intake → T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.
  • ChangedBefore Aspiration Risk Based on Gastric VolumeNow Proportion of Participants Exceeding the High Gastric Volume Threshold (>1.5 mL/kg)Time frame: Two hours after oral clear fluid intake before anesthesia → T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.
Oct 7, 2026
Design
Study type Observational→Interventional
Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Recruiting→Completed
    Enrollment 80 (estimated)→95 (actual)
    Eligibility 2 inclusion criteria edited, 2 added; 1 exclusion criterion edited, 8 added, 3 removed
    What changed in the criteria
    Inclusion criteria
    • EditedScheduled for elective cesarean section under spinal anesthesiadelivery
    • EditedASA physical status II or III
    • AddedNo contraindication to regional anesthesia
    • AddedCompliance with standard preoperative fasting requirements
    Exclusion criteria
    • AddedActive labor
    • EditedContraindication to spinalregional anesthesia
    • RemovedKnown allergy to study medications
    • RemovedMultiple pregnancy
    • RemovedSevere systemic disease (ASA III or higher)
    • AddedPreviously diagnosed diabetic gastroparesis
    • AddedPregestational diabetes mellitus (type 1 or type 2)
    • AddedHistory of upper gastrointestinal disease or gastroesophageal reflux disease
    • AddedHistory of esophageal, gastric, or upper abdominal surgery
    • AddedAnatomical abnormalities of the upper gastrointestinal tract
    • AddedASA physical status IV or higher
    • AddedInability to adequately visualize the gastric antrum by ultrasonography
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Gastric Volume Measured by UltrasonographyNow Gastric Volume Across Three Time PointsTime frame: Before oral clear fluid intake and two hours after fluid intake before anesthesia → T1: after standard preoperative fasting, immediately before intake of 200 mL water; T2: immediately after completion of 200 mL water intake; T3: 2 hours after water intake, immediately before anesthesia.
    Secondary outcomes 2 edited
    What changed in the outcomes
    • EditedQualitative Assessment of Gastric Contents Using the Perlas Grading SystemTime frame: Before oral clear fluid intake and two hours after fluid intake → T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.
    • ChangedBefore Aspiration Risk Based on Gastric VolumeNow Proportion of Participants Exceeding the High Gastric Volume Threshold (>1.5 mL/kg)Time frame: Two hours after oral clear fluid intake before anesthesia → T1: before 200 mL water intake; T2: immediately after 200 mL water intake; T3: 2 hours after water intake.
    Interventions Arms added: Gestational Diabetes Mellitus (GDM) Group·Control Group; arms removed: Diabetic Pregnant Women·Non-Diabetic Pregnant Women
    Design Study type Observational→Interventional
    + 7 other changes: index terms, verification date, date precision, description, conditions, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07482098
Responsible party
Esra Uyar Türkyılmaz (associate professor MD, Ankara City Hospital Bilkent) — Principal investigator
First posted
Mar 19, 2026
Start date
Dec 1, 2025
Primary completion
Jul 29, 2026
Completion
Jul 29, 2026
Last update
Oct 15, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion